Dr. Kristen Nooshin Ganjoo, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Stanford, CA
She has not yet shared a personalized biography with Doctor.com.
| Institution | Focus | Year |
|---|---|---|
| Internship - Indiana University | 1995 | |
| Internship - Indiana University, Bachelor of Science In Business, Bloomington, Indiana | 1995 | |
| Residency - Indiana University | 1997 | |
| Fellowship - Indiana University / School of Medicine | 2000 |
| Certification | Cert. Body | Year |
|---|---|---|
Sub-Specialty: Medical Oncology | Internal Medicine | 2000 |
| Position | Organization | Time |
|---|---|---|
| Assistant Professor of Medicine (Oncology) | the Stanford University Medical Center | Present |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | Jourl of the tiol Comprehensive Cancer Network | Gastrointestil stromal tumors, version 2.2014. | 2014 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma, Version 2.2014 Featured Updates to the NCCN Guidelines | 2014 |
| Other Publication | Anls of oncology | A multicenter phase II study of pazopanib in patients with advanced gastrointestil stromal tumors | 2014 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | R1507, a Monoclol Antibody to the Insulin-Like Growth Factor 1 Receptor | 2011 |
| Other Publication | DRUGS | Current and Emerging Pharmacological Treatments for Gastrointestil Stromal Tumour | 2011 |
| Other Publication | ONCOLOGY | A Phase I Study of the Safety | 2011 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma | 2010 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | NCCN Task Force Report: Update on the Magement of Patients with Gastrointestil Stromal Tumors | 2010 |
| Other Publication | LEUKEMIA & LYMPHOMA | Acute myeloid leukemia in patients with gastrointestil stromal tumors treated with Gleevec | 2009 |
| Other Publication | Leukemia & lymphoma | Bevacizumab and cyclosphosphamide, doxorubicin | 2014 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early | 2012 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma, Version 2.2012 Featured Updates to the NCCN Guidelines | 2012 |
| Other Publication | LEUKEMIA & LYMPHOMA | Cardiac toxicity associated with bevacizumab | 2012 |
| Other Publication | CANCER INVESTIGATION | Maintence Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced | 2012 |
| Other Publication | CLINICAL CANCER RESEARCH | Results of a Phase 1 Study of AME-133v (LY2469298) | 2012 |
| Other Publication | AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study | 2011 |
| Other Publication | JOURL OF THORACIC ONCOLOGY | A Phase II First-Line Study of Gemcitabine, Carboplatin | 2010 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (Zevali (R)) Therapy of Low-Grade Refractory | 2010 |
| Other Publication | AMERICAN JOURL OF PATHOLOGY | Coordite Expression of Colony-Stimulating Factor-1 | 2009 |
| Other Publication | JOURL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | The importance of angiogenesis markers | 2008 |
| Other Publication | AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | A phase II study of single agent gemcitabine | 2005 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Unusual locations of involvement by maligncies - Case 1. Testicular plasmacytoma | 2003 |
| Other Publication | JOURL OF UROLOGY | Germ cell tumor associated primitive neuroectodermal tumors | 2001 |
| Other Publication | Ganjoo, K. N., Rieger, K. M., Kesler, K. A., Sharma, M., Heilman, D. K | Results of modern therapy for patients with mediastil nonseminomatous germ cell tumors | 2000 |
| Other Publication | Kesler, K. A., Rieger, K. M., Ganjoo, K. N., Sharma, M., Fineberg, N. | Primary mediastil nonseminomatous germ cell tumors | 1999 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Lung cancer presenting with solitary bone metastases - Case 1 | 1999 |
| Other Publication | Journal of the National Comprehensive Cancer Network | Gastrointestinal stromal tumors, version 2.2014. | 2014 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma, Version 2.2014 Featured Updates to the NCCN Guidelines | 2014 |
| Other Publication | Annals of oncology | A multicenter phase II study of pazopanib | 2014 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor | 2011 |
| Other Publication | DRUGS | Current and Emerging Pharmacological Treatments for Gastrointestinal Stromal Tumour | 2011 |
| Other Publication | ONCOLOGY | A Phase I Study of the Safety | 2011 |
| Other Publication | CURRENT ONCOLOGY REPORTS | New Developments in Targeted Therapy for Soft Tissue Sarcoma | 2010 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma | 2010 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors | 2010 |
| Other Publication | CANCER | Antiangiogenesis Agents in the Treatment of Soft Tissue Sarcomas | 2010 |
| Other Publication | EXPERT OPINION ON PHARMACOTHERAPY | Trabectedin: an anticancer drug from the sea | 2009 |
| Other Publication | LEUKEMIA & LYMPHOMA | Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec | 2009 |
| Other Publication | Leukemia & lymphoma | Bevacizumab and cyclosphosphamide, doxorubicin | 2014 |
| Other Publication | Current oncology reports | The Treatment Outcome for Adult Patients with Ewing's Sarcoma. | 2013 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early | 2012 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Soft Tissue Sarcoma, Version 2.2012 Featured Updates to the NCCN Guidelines | 2012 |
| Other Publication | LEUKEMIA & LYMPHOMA | Cardiac toxicity associated with bevacizumab | 2012 |
| Other Publication | CANCER INVESTIGATION | Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced | 2012 |
| Other Publication | CLINICAL CANCER RESEARCH | Results of a Phase 1 Study of AME-133v (LY2469298) | 2012 |
| Other Publication | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study | 2011 |
| Other Publication | JOURNAL OF THORACIC ONCOLOGY | A Phase II First-Line Study of Gemcitabine, Carboplatin | 2010 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (ZevalinA (R)) Therapy of Low-Grade Refractory | 2010 |
| Other Publication | CANCER | Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory | 2010 |
| Other Publication | Clement-Duchene, C., Krupitskaya, Y., Ganjoo, K., Lavori, P., Kumar, A | A phase II first line study of gemcitabine | 2009 |
| Other Publication | AMERICAN JOURNAL OF PATHOLOGY | Coordinate Expression of Colony-Stimulating Factor-1 | 2009 |
| Other Publication | Krupitskaya, Y., Ganjoo, K., Lavori, P. W., Kumar, A., Clement-Duchene | A phase II first-line study of gemcitabine, carboplatin | |
| Other Publication | Case reports in oncology | Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor. | 2009 |
| Other Publication | Case Reports in Oncology | Breast angiosarcomas: Case series and expression of vascular endothelial growth factor | 2009 |
| Other Publication | LEUKEMIA & LYMPHOMA | Opportunistic enteroviral meningoencephalitis | 2009 |
| Other Publication | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | The importance of angiogenesis markers | 2008 |
| Other Publication | Biologics; Targets & Therapy | Review of erlotinib in the treatement of advanced non-small cell lung cancer | |
| Other Publication | Biologics : targets & therapy | Review of erlotinib in the treatment of advanced non-small cell lung cancer. | 2007 |
| Other Publication | CANCER | Non-Hodgkin lymphoma of the breast | 2007 |
| Other Publication | LEUKEMIA & LYMPHOMA | Antiangiogenesis: A new approach to the treatment of lymphoma | 2007 |
| Other Publication | LEUKEMIA & LYMPHOMA | Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety | 2006 |
| Other Publication | CANCER | Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein | 2006 |
| Other Publication | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | A phase II study of single agent gemcitabine | 2005 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Unusual locations of involvement by malignancies - Case 1. Testicular plasmacytoma | 2003 |
| Other Publication | ONCOLOGY | Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer | 2003 |
| Other Publication | ONCOLOGY | A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer | 2002 |
| Other Publication | JOURNAL OF UROLOGY | Germ cell tumor associated primitive neuroectodermal tumors | 2001 |
| Other Publication | Ganjoo, K. N., Rieger, K. M., Kesler, K. A., Sharma, M., Heilman, D. K | Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors | 2000 |
| Other Publication | Ganjoo, K. N., Chan, R. J., Sharma, M., Einhorn, L. H. | Positron emission tomography scans in the evaluation of postchemotherapy residual m | 1999 |
| Other Publication | Kesler, K. A., Rieger, K. M., Ganjoo, K. N., Sharma, M., Fineberg, N. | Primary mediastinal nonseminomatous germ cell tumors | 1999 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Lung cancer presenting with solitary bone metastases - Case 1 | 1999 |
Dr. Kristen Nooshin Ganjoo, MD has not yet indicated the hospitals that she is affiliated with.
Accepts New Patients: Yes
Dr. Kristen Nooshin Ganjoo, MD has not yet listed the medications that she commonly prescribes.
Dr. Kristen Nooshin Ganjoo, MD has not yet added any information about her practice's billing policies and payment options.
